Press Release – April 27, 2018 Medpace was recognized with the first-ever ACRP-Avoca CRO Quality Award today during the ACRP-Avoca Awards and Recognition Ceremony taking place at the ACRP 2018 annual meeting. The Association of Clinical Research Professionals and The Avoca Group jointly recognized leading CROs at the event. The following ACRP-Avoca CRO Quality Awards […]
Read MorePress Release – April 27, 2018 Abbott Laboratories was recognized with the first-ever ACRP-Avoca Sponsor Quality Award today during the ACRP-Avoca Awards and Recognition Ceremony taking place at the ACRP 2018 annual meeting. The Association of Clinical Research Professionals and The Avoca Group jointly recognized leading sponsors at the event. The following ACRP-Avoca Sponsor Quality […]
Read MoreApril 27, 2018 | National Harbor, MD
In conjunction with the ACRP Annual Meeting and the Avoca Quality Consortium®, this one-day event will offer participants an unparalleled view of the changing clinical trial landscape and transformational approaches to improving clinical research quality.
April 17, 2018 | 11:00am - 12:00pm EDT
Knowledge Center Patient Engagement Overview
March 21, 2018 | 11:00am - 12:00pm EDT
Inspection Preparation With a Risk-Based Approach Consistent with ICH E6 (R2) Requirements
March 19-21, 2018 | Philadelphia, PA
Join Avoca for a presentation outlining a practical approach for identifying and measuring risk in clinical trial operations.
By Cristin MacDonald, PhD, Executive Director of Client Delivery, The Avoca Group Clinical Leader – March 15, 2018 The purpose of a comprehensive assessment system is to support structured, systematic, objective, and rational decision making. This holds true even when assessing something as difficult to pin down as risk. The Avoca Quality Consortium (AQC) takes […]
Read MoreBy Andrew Burrows, KNect365 KNect365 Life Sciences – March 14, 2018 KNect365 spoke to Patricia Leuchten, President and CEO at The Avoca Group, as part of PCT TV at Partnerships in Clinical Trials Europe (Nov 2017) about how the clinical trials industry should interpret the ICH E6 R2 guidelines and the biggest challenges to […]
Read More